Conquering Diseases

A Study Of An Investigational Drug In Male Participants With Fragile X Syndrome


Seeking Men aged 13 to 40 years of age with Fragile X Syndrome for study of an investigational drug alone and/ or in combination with other drugs.


We are studying the effects of an investigational drug called Sulindac (HX02_01) and how safe and well this drug works alone or in combination with other drugs for male patients with Fragile X Syndrome.

What we're hoping for

Evaluate the safety and how well Sulindac works alone or in combination with other drugs in patients with Fragile X Syndrome

Additional Information Identifier: NCT04823052

 Principal Investigator

Jean  Frazier, MD

UMass Memorial Health Care

 Study Contact

Lauren  Venuti

+1 774-455-4113


UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655